New research demonstrates the importance of negative results, says Torsten Rackoll […]
Author’s perspective
Gauging the validity of cancer drug trials: a call for collaboration
In a new research paper published in The BMJ, we examine the evidence base supporting the European Medicines Agency (EMA)’s approval of cancer drugs. Of 32 new cancer drugs approved […]
Ulf Ekelund and Thomas Yates: “Sit less—move more and more often”: all physical activity is beneficial for longevity
New research shows that any level of movement decreases risk of premature death, so get moving say Ulf Ekelund and Thomas Yates […]
Jian-Meng Liu: The cast of thousands behind our data
Jian-Meng Liu discusses the logistics of recording birthrates in a country as large and diverse as China […]
Lee Hooper and Asmaa Abdelhamid: The role of nutrition in disease prevention—how we can find better answers?
How can we get more information from dietary trials? It’s simple really. Often dietary interventions are trialled against a wide range of health outcomes—so there may be two trials assessing […]
Séverine Sabia and Archana Singh-Manoux: The implications of cardiovascular health for dementia
Séverine Sabia and Archana Singh-Manoux explain what the findings of their latest study tell us about preventing dementia […]
Simiao Chen: The power of awareness
Community-based hypertension screening in China is testament to the adage prevention is better than cure says Simiao Chen. […]
Data sharing in clinical trials: keeping score
The Good Pharma Scorecard is a vital tool in ensuring ethical and responsible data-sharing, say Jennifer E. Miller and Amy Price. […]
Maria Brandkvist: Destigmatising obesity by understanding the impact of genes
As a young adult I moved from Toronto to Stockholm to start my studies in medicine. Although the values of Swedes and Canadians are similar, my first impressions revealed some visible […]
Investigating the causes of death attributable to use of proton pump inhibitors
Over the past decade, a number of studies have suggested that use of proton pump inhibitors is associated with increased risk of several adverse health outcomes including cardiovascular disease, acute […]